Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.

Genetic changes in epithelial cells initiate the development of prostatic adenocarcinomas. As nascent tumors grow and undergo progression, epithelial tumor cells are intimately associated with stromal cells. Stromal cells within the tumor microenvironment acquire new properties, including the capacity to promote phenotypic and genetic progression in adjacent epithelial cells. Affymetrix microarrays were used to identify 119 genes differentially expressed between normal-derived and carcinoma-derived prostatic stromal cells. These included 31 genes encoding extracellular proteins that may act as stromal-to-epithelial paracrine signals. Further investigation of one of these genes, secreted frizzled related protein 1 (SFRP1), revealed that its expression parallels prostatic growth with high expression during prostatic development, low expression in the adult prostate, and elevated expression in prostatic tumor stroma. In addition, as prostatic epithelial cells progressed to a tumorigenic state under the influence of tumor stroma, SFRP1 became overexpressed in the progressed epithelial cells. To further understand the roles of SFRP1 in the prostate, we tested the affects of increased SFRP1 levels on prostatic tissues and cells. Treatment of developing prostates with SFRP1 in culture led to increased organ growth. Treatment of a human prostatic epithelial cell line with SFRP1 led to increased proliferation, decreased apoptosis, and decreased signaling through the Wnt/beta-catenin pathway in vitro and increased proliferation in vivo. These data suggest that overexpression of SFRP1 by prostatic tumor stroma may account for the previously reported capacity of prostatic tumor stroma to provide a pro-proliferative paracrine signal to adjacent epithelial cells.

[1]  Randall T Moon,et al.  Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways , 1999, Oncogene.

[2]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  H. Varmus,et al.  Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Yvonne Wallis,et al.  The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.

[5]  N. Gale,et al.  Immunohistochemical analysis of pro- and active-caspase 3 in laryngeal squamous cell carcinoma , 2004, Virchows Archiv.

[6]  W. Isaacs,et al.  In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis , 2002, Oncogene.

[7]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[8]  Victor G Corces,et al.  Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. , 2004, Trends in genetics : TIG.

[9]  Ching-Jin Chang,et al.  Autocrine/Paracrine Secreted Frizzled-related Protein 2 Induces Cellular Resistance to Apoptosis , 2004, Journal of Biological Chemistry.

[10]  M. Gleave,et al.  Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. , 1992, The Journal of urology.

[11]  W. Linehan,et al.  The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. , 2001, Cancer research.

[12]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[13]  S. Hayward,et al.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.

[14]  T. Timme,et al.  Genetic predisposition and mesenchymal‐epithelial interactions in ras + myc—induced carcinogenesis in reconstituted mouse prostate , 1993, Molecular carcinogenesis.

[15]  Biao He,et al.  Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma , 2004, Oncogene.

[16]  A. Üren,et al.  Secreted Frizzled-related Protein-1 Binds Directly to Wingless and Is a Biphasic Modulator of Wnt Signaling* , 2000, The Journal of Biological Chemistry.

[17]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[18]  J. Kench,et al.  Lower levels of nuclear β‐catenin predict for a poorer prognosis in localized prostate cancer , 2005, International journal of cancer.

[19]  P. Polakis Wnt signaling and cancer. , 2000, Genes & development.

[20]  D. Rowley What Might A Stromal Response Mean to Prostate Cancer Progression? , 1998, Cancer and Metastasis Reviews.

[21]  L. Chung,et al.  Co‐inoculation of tumorigenic rat prostate mesenchymal cells with non‐tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals , 1989, International journal of cancer.

[22]  I. Mowszowicz,et al.  Transforming growth factor β in the human prostate: Its role in stromal–epithelial interactions in non‐cancerous cell culture , 2001, The Prostate.

[23]  Y. Wong,et al.  Influence of male genital tract mesenchymes on differentiation of Dunning prostatic adenocarcinoma. , 1990, Cancer research.

[24]  Z. Hall Cancer , 1906, The Hospital.

[25]  M. Gleave,et al.  Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. , 1991, Cancer research.

[26]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[27]  S. Fujii,et al.  Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. , 2002, The Journal of clinical endocrinology and metabolism.

[28]  C. Thut,et al.  A large-scale in situ screen provides molecular evidence for the induction of eye anterior segment structures by the developing lens. , 2001, Developmental biology.

[29]  M. Mahadevappa,et al.  SARPs: a family of secreted apoptosis-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Y. Taketani,et al.  Methylation‐associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers , 2004, Cancer science.

[31]  S. Baylin,et al.  Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer , 2004, Laboratory Investigation.

[32]  J. Papkoff,et al.  A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates wnt-1 signaling. , 1999, Journal of cell science.

[33]  S. Amar,et al.  Secreted Frizzled-related Protein 1 (SFRP1) Protects Fibroblasts from Ceramide-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[34]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[35]  T. Hsu,et al.  Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Hayward,et al.  Stromal-epithelial interactions in the normal and neoplastic prostate. , 1997, British journal of urology.

[37]  T Visakorpi,et al.  Molecular genetics of prostate cancer. , 2001, Annals of medicine.

[38]  W. Isaacs,et al.  Detection and analysis of β‐catenin mutations in prostate cancer , 2000 .

[39]  S. Hayward,et al.  Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[41]  S. Linder,et al.  Up‐regulation of human secreted frizzled homolog in apoptosis and its down‐regulation in breast tumors , 1998, International journal of cancer.

[42]  G. Cunha,et al.  Effects of mesenchyme of the embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study. , 1992, Acta anatomica.

[43]  J. Nathans,et al.  A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Potti,et al.  Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. , 2004, Cancer.

[45]  R. Dahiya,et al.  Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1 , 2007, In Vitro Cellular & Developmental Biology - Animal.

[46]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.